Healthcare Sector Stocks
The Healthcare sector has a total of 1048 stocks, with a combined market cap of $10.07 trillion, total revenue of $4.74 trillion and a weighted average PE ratio of 47.10.
Market Cap
10.07T
Revenue
4.74T
Profits
213.89B
PE Ratio
47.10
Profit Margin
4.51%
Dividend Yield
0.37%
1047 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.28T | 1.15% | 1,378,900 | 86.46B |
| 2 | JNJ | Johnson & Johnson | 688.97B | 0.95% | 3,267,389 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 520.93B | 0.09% | 2,008,633 | 66.01B |
| 4 | MRK | Merck & Co., Inc. | 364.56B | 0.63% | 3,474,272 | 67.38B |
| 5 | UNH | UnitedHealth Group Incorporated | 364.52B | 0.42% | 2,207,142 | 450.06B |
| 6 | NVS | Novartis AG | 302.43B | 0.12% | 1,154,436 | 57.36B |
| 7 | AZN | AstraZeneca PLC | 286.54B | 0.20% | 1,506,065 | 62.38B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 258.94B | -0.08% | 1,278,108 | 47.35B |
| 9 | AMGN | Amgen Inc. | 251.97B | -0.26% | 686,201 | 38.90B |
| 10 | GILD | Gilead Sciences, Inc. | 208.22B | -0.04% | 1,995,257 | 30.99B |
| 11 | ABT | Abbott Laboratories | 187.95B | 1.18% | 3,908,956 | 48.23B |
| 12 | NVO | Novo Nordisk A/S | 183.58B | 2.07% | 8,708,450 | 50.70B |
| 13 | PFE | Pfizer Inc. | 164.16B | -0.10% | 14,858,806 | 63.62B |
| 14 | DHR | Danaher Corporation | 164.01B | 0.41% | 2,090,193 | 25.61B |
| 15 | ISRG | Intuitive Surgical, Inc. | 154.36B | 1.23% | 966,525 | 11.58B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 136.57B | -0.73% | 364,216 | 12.95B |
| 17 | BMY | Bristol-Myers Squibb Company | 129.26B | 1.47% | 5,929,739 | 50.03B |
| 18 | MCK | McKesson Corporation | 127.17B | 2.27% | 306,879 | 418.79B |
| 19 | MDT | Medtronic plc | 125.74B | 1.71% | 3,170,635 | 37.54B |
| 20 | SYK | Stryker Corporation | 117.40B | -1.28% | 2,405,226 | 26.30B |
| 21 | SNY | Sanofi | 115.58B | -0.21% | 1,274,444 | 57.89B |
| 22 | CVS | CVS Health Corporation | 113.74B | -1.00% | 5,132,607 | 418.16B |
| 23 | HCA | HCA Healthcare, Inc. | 104.19B | -0.38% | 531,999 | 78.70B |
| 24 | GSK | GSK plc | 101.11B | 0.67% | 1,917,356 | 44.53B |
| 25 | REGN | Regeneron Pharmaceuticals, Inc. | 95.93B | 0.50% | 363,840 | 16.90B |
| 26 | ELV | Elevance Health, Inc. | 92.47B | -0.44% | 443,014 | 201.83B |
| 27 | MRNA | Moderna, Inc. | 90.36B | -3.47% | 6,206,847 | 2.53B |
| 28 | CI | The Cigna Group | 77.87B | -0.25% | 852,252 | 286.32B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 70.22B | 1.47% | 2,997,075 | 29.86B |
| 30 | COR | Cencora, Inc. | 68.36B | 2.73% | 794,242 | 337.40B |
| 31 | CAH | Cardinal Health, Inc. | 64.95B | 1.04% | 775,342 | 257.75B |
| 32 | BSX | Boston Scientific Corporation | 64.18B | 0.18% | 7,003,939 | 21.07B |
| 33 | EW | Edwards Lifesciences Corporation | 61.69B | 1.41% | 2,421,515 | 6.67B |
| 34 | ARGX | argenx SE | 59.45B | -1.94% | 176,913 | 5.92B |
| 35 | BDX | Becton, Dickinson and Company | 59.15B | 0.68% | 1,033,979 | 19.46B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 55.48B | 0.89% | 218,133 | 4.66B |
| 37 | HUM | Humana Inc. | 53.77B | 0.90% | 792,767 | 154.19B |
| 38 | MDLN | Medline Inc. | 51.85B | -1.40% | 3,898,233 | 30.68B |
| 39 | TEVA | Teva Pharmaceutical Industries Limited | 51.83B | 1.76% | 4,750,508 | 17.23B |
| 40 | A | Agilent Technologies, Inc. | 49.02B | 0.50% | 667,602 | 7.37B |
| 41 | VEEV | Veeva Systems Inc. | 48.78B | -0.38% | 503,631 | 3.46B |
| 42 | ONC | BeOne Medicines AG | 47.52B | 0.01% | 133,319 | 6.45B |
| 43 | NTRA | Natera, Inc. | 46.44B | -0.83% | 989,607 | 2.91B |
| 44 | WAT | Waters Corporation | 45.27B | -0.35% | 376,630 | 5.61B |
| 45 | IQV | IQVIA Holdings Inc. | 43.90B | -1.74% | 1,007,124 | 17.31B |
| 46 | HLN | Haleon plc | 40.42B | 0.83% | 14,475,071 | 14.80B |
| 47 | RPRX | Royalty Pharma plc | 39.76B | 0.84% | 2,082,724 | 2.62B |
| 48 | BIIB | Biogen Inc. | 37.61B | 1.58% | 613,665 | 10.30B |
| 49 | GEHC | GE HealthCare Technologies Inc. | 37.47B | 1.27% | 1,314,345 | 21.64B |
| 50 | RVMD | Revolution Medicines, Inc. | 37.29B | -2.24% | 2,067,241 | 197.56M |
| 51 | ALC | Alcon Inc. | 35.67B | 2.83% | 1,902,117 | 10.98B |
| 52 | CNC | Centene Corporation | 35.13B | 0.98% | 2,276,255 | 180.41B |
| 53 | MTD | Mettler-Toledo International Inc. | 34.54B | 0.32% | 86,522 | 4.20B |
| 54 | ZTS | Zoetis Inc. | 33.97B | 0.77% | 1,938,682 | 9.49B |
| 55 | RMD | ResMed Inc. | 33.68B | 0.22% | 518,749 | 5.73B |
| 56 | GMAB | Genmab A/S | 32.77B | -0.85% | 2,813,684 | 4.30B |
| 57 | ILMN | Illumina, Inc. | 31.43B | -0.81% | 761,773 | 4.54B |
| 58 | DXCM | DexCom, Inc. | 31.12B | 2.51% | 1,806,853 | 5.10B |
| 59 | LH | Labcorp Holdings Inc. | 30.05B | -0.59% | 252,384 | 14.59B |
| 60 | PHG | Koninklijke Philips N.V. | 29.81B | 0.73% | 1,003,908 | 20.16B |
| 61 | WST | West Pharmaceutical Services, Inc. | 28.96B | 1.08% | 255,542 | 3.40B |
| 62 | DGX | Quest Diagnostics Incorporated | 28.49B | -0.28% | 352,994 | 11.84B |
| 63 | ROIV | Roivant Sciences Ltd. | 28.46B | -1.76% | 4,719,356 | 41.08M |
| 64 | INSM | Insmed Incorporated | 26.58B | 2.62% | 877,165 | 1.52B |
| 65 | STE | STERIS plc | 25.58B | 3.95% | 598,593 | 6.17B |
| 66 | UTHR | United Therapeutics Corporation | 25.34B | 0.28% | 241,721 | 3.19B |
| 67 | INCY | Incyte Corporation | 24.65B | -0.63% | 518,396 | 6.01B |
| 68 | VTRS | Viatris Inc. | 23.85B | 0.65% | 3,569,360 | 14.73B |
| 69 | THC | Tenet Healthcare Corporation | 22.69B | -0.63% | 241,230 | 22.15B |
| 70 | ALNY | Alnylam Pharmaceuticals, Inc. | 22.04B | 5.05% | 2,547,116 | 5.01B |
| 71 | BNTX | BioNTech SE | 21.17B | 0.42% | 625,325 | 2.75B |
| 72 | GH | Guardant Health, Inc. | 20.63B | -1.55% | 923,127 | 1.28B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 19.50B | -1.45% | 1,699,283 | 8.57B |
| 74 | MEDP | Medpace Holdings, Inc. | 18.36B | -0.08% | 63,065 | 2.84B |
| 75 | ASND | Ascendis Pharma A/S | 18.10B | 3.31% | 593,038 | 1.37B |
| 76 | RVTY | Revvity, Inc. | 17.32B | -1.20% | 918,639 | 2.94B |
| 77 | NBIX | Neurocrine Biosciences, Inc. | 16.97B | -1.05% | 822,264 | 3.70B |
| 78 | EXEL | Exelixis, Inc. | 16.87B | -1.03% | 924,597 | 2.50B |
| 79 | CRL | Charles River Laboratories International, Inc. | 16.24B | -0.53% | 340,617 | 3.98B |
| 80 | JAZZ | Jazz Pharmaceuticals plc | 15.56B | 0.83% | 310,967 | 4.72B |
| 81 | BBIO | BridgeBio Pharma, Inc. | 15.26B | 0.22% | 674,040 | 945.54M |
| 82 | SOLV | Solventum Corporation | 15.03B | -0.28% | 325,163 | 8.16B |
| 83 | BTSG | BrightSpring Health Services, Inc. | 14.80B | -0.60% | 984,331 | 15.25B |
| 84 | ICLR | ICON Public Limited Company | 14.64B | -2.54% | 626,623 | 8.23B |
| 85 | GKOS | Glaukos Corporation | 14.59B | 0.25% | 339,361 | 690.33M |
| 86 | EHC | Encompass Health Corporation | 13.82B | -0.02% | 305,414 | 6.34B |
| 87 | ELAN | Elanco Animal Health Incorporated | 13.37B | 0.94% | 3,036,979 | 5.15B |
| 88 | BAX | Baxter International Inc. | 13.32B | 0.06% | 2,946,456 | 11.61B |
| 89 | SNN | Smith & Nephew plc | 13.04B | 0.68% | 1,106,135 | 6.30B |
| 90 | TEM | Tempus AI, Inc. | 13.01B | -6.04% | 4,292,170 | 1.51B |
| 91 | PEN | Penumbra, Inc. | 12.65B | 0.06% | 173,224 | 1.56B |
| 92 | RDY | Dr. Reddy's Laboratories Limited | 12.22B | 0.48% | 1,137,074 | 3.44B |
| 93 | COO | The Cooper Companies, Inc. | 11.97B | 1.21% | 857,235 | 4.24B |
| 94 | ALGN | Align Technology, Inc. | 11.85B | 0.70% | 384,148 | 4.16B |
| 95 | FMS | Fresenius Medical Care AG | 11.58B | 2.01% | 1,051,350 | 22.12B |
| 96 | MTRI | Mentari Therapeutics, Inc. | 11.48B | 4.03% | 11,759 | - |
| 97 | HALO | Halozyme Therapeutics, Inc. | 11.45B | -0.26% | 1,581,412 | 1.80B |
| 98 | TECH | Bio-Techne Corporation | 11.44B | 0.05% | 1,658,276 | 1.23B |
| 99 | SMMT | Summit Therapeutics Inc. | 11.34B | -5.97% | 4,261,941 | - |
| 100 | UHS | Universal Health Services, Inc. | 11.22B | 0.36% | 188,913 | 18.35B |
| 101 | BMRN | BioMarin Pharmaceutical Inc. | 11.07B | 0.81% | 617,639 | 3.66B |
| 102 | DVA | DaVita Inc. | 10.94B | -0.16% | 415,730 | 14.17B |
| 103 | KYMR | Kymera Therapeutics, Inc. | 10.93B | 0.66% | 517,428 | 102.24M |
| 104 | MOH | Molina Healthcare, Inc. | 10.92B | -0.07% | 205,039 | 42.08B |
| 105 | ENSG | The Ensign Group, Inc. | 10.90B | 0.99% | 150,226 | 5.67B |
| 106 | RGEN | Repligen Corporation | 10.73B | 0.77% | 354,340 | 805.61M |
| 107 | PODD | Insulet Corporation | 10.61B | 2.49% | 848,175 | 3.19B |
| 108 | AVTR | Avantor, Inc. | 10.54B | -0.42% | 4,743,203 | 6.64B |
| 109 | QGEN | Qiagen N.V. | 10.30B | -0.41% | 1,232,956 | 2.12B |
| 110 | PCVX | Vaxcyte, Inc. | 10.06B | -1.81% | 391,294 | - |
| 111 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.94B | 0.60% | 258,010 | 1.43B |
| 112 | SYRE | Spyre Therapeutics, Inc. | 9.88B | 1.06% | 506,139 | - |
| 113 | BIO | Bio-Rad Laboratories, Inc. | 9.84B | -1.24% | 165,444 | 2.59B |
| 114 | OSCR | Oscar Health, Inc. | 9.68B | -2.38% | 3,027,627 | 17.47B |
| 115 | GMED | Globus Medical, Inc. | 9.56B | -0.24% | 1,015,143 | 3.14B |
| 116 | HSIC | Henry Schein, Inc. | 9.55B | 0.27% | 1,672,073 | 13.73B |
| 117 | BRKR | Bruker Corporation | 9.39B | 1.89% | 1,356,854 | 3.51B |
| 118 | HNGE | Hinge Health, Inc. | 9.37B | -4.70% | 921,229 | 800.82M |
| 119 | PRAX | Praxis Precision Medicines, Inc. | 9.14B | 0.73% | 247,918 | 7.46M |
| 120 | KRYS | Krystal Biotech, Inc. | 9.06B | 0.00% | 64,830 | 470.03M |
| 121 | ATR | AptarGroup, Inc. | 9.05B | 0.73% | 266,536 | 3.99B |
| 122 | TGTX | TG Therapeutics, Inc. | 9.02B | -0.31% | 656,199 | 897.76M |
| 123 | PTGX | Protagonist Therapeutics, Inc. | 8.55B | -2.52% | 482,819 | 551.69M |
| 124 | HQY | HealthEquity, Inc. | 8.54B | 0.23% | 343,798 | 1.36B |
| 125 | CORT | Corcept Therapeutics Incorporated | 8.05B | -0.18% | 764,641 | 963.65M |
| 126 | RYTM | Rhythm Pharmaceuticals, Inc. | 8.00B | 5.10% | 800,030 | 280.75M |
| 127 | ALKS | Alkermes plc | 7.91B | 0.26% | 1,042,955 | 1.75B |
| 128 | CYTK | Cytokinetics, Incorporated | 7.83B | 0.11% | 631,327 | 113.29M |
| 129 | TXG | 10x Genomics, Inc. | 7.68B | -1.27% | 1,604,349 | 618.58M |
| 130 | PACS | PACS Group, Inc. | 7.66B | 0.56% | 294,662 | 5.71B |
| 131 | GRFS | Grifols, S.A. | 7.59B | -1.19% | 255,761 | 8.63B |
| 132 | BLCO | Bausch + Lomb Corporation | 7.54B | -0.19% | 377,056 | 5.42B |
| 133 | KNSA | Kiniksa Pharmaceuticals International, plc | 7.53B | -0.42% | 317,371 | 945.96M |
| 134 | AMRX | Amneal Pharmaceuticals, Inc. | 7.46B | -1.29% | 1,067,375 | 3.20B |
| 135 | AXSM | Axsome Therapeutics, Inc. | 7.45B | -1.88% | 674,601 | 865.27M |
| 136 | ABVX | ABIVAX Société Anonyme | 7.38B | -3.04% | 531,665 | 5.33M |
| 137 | KOD | Kodiak Sciences Inc. | 7.29B | 3.19% | 573,490 | - |
| 138 | ORKA | Oruka Therapeutics, Inc. | 7.20B | 1.10% | 426,192 | - |
| 139 | CHE | Chemed Corporation | 7.12B | -0.12% | 44,996 | 2.66B |
| 140 | IMVT | Immunovant, Inc. | 7.08B | -2.43% | 479,942 | - |
| 141 | TWST | Twist Bioscience Corporation | 7.05B | -1.59% | 1,675,027 | 459.43M |
| 142 | BLTE | Belite Bio, Inc | 6.73B | -1.61% | 188,756 | - |
| 143 | ARWR | Arrowhead Pharmaceuticals, Inc. | 6.67B | 0.00% | 2,245,955 | 450.82M |
| 144 | LNTH | Lantheus Holdings, Inc. | 6.65B | 0.38% | 521,936 | 1.56B |
| 145 | CGON | CG Oncology, Inc. | 6.61B | 5.49% | 1,672,454 | 6.17M |
| 146 | CAI | Caris Life Sciences, Inc. | 6.59B | -4.09% | 2,189,600 | 1.05B |
| 147 | IBRX | ImmunityBio, Inc. | 6.46B | 0.00% | 11,551,242 | 182.57M |
| 148 | LGND | Ligand Pharmaceuticals Incorporated | 6.20B | -2.01% | 77,942 | 253.83M |
| 149 | SUPN | Supernus, Inc. | 6.16B | 1.61% | 971,289 | 1.37B |
| 150 | TFX | Teleflex Incorporated | 6.14B | 1.14% | 533,388 | 2.26B |
| 151 | MIRM | Mirum Pharmaceuticals, Inc. | 6.11B | 0.34% | 170,719 | 670.78M |
| 152 | RDNT | RadNet, Inc. | 6.01B | 0.38% | 257,578 | 2.38B |
| 153 | DOCS | Doximity, Inc. | 5.95B | 0.45% | 867,134 | 661.58M |
| 154 | HAE | Haemonetics Corporation | 5.59B | -0.01% | 301,125 | 1.38B |
| 155 | MANE | Veradermics, Incorporated | 5.43B | -4.89% | 717,484 | - |
| 156 | ERAS | Erasca, Inc. | 5.43B | -2.03% | 7,009,195 | - |
| 157 | CON | Concentra Group Holdings Parent, Inc. | 5.42B | -0.40% | 363,195 | 2.34B |
| 158 | WAY | Waystar Holding Corp. | 5.40B | -0.18% | 682,587 | 1.26B |
| 159 | LFST | LifeStance Health Group, Inc. | 5.33B | -0.95% | 2,280,413 | 1.68B |
| 160 | PTCT | PTC Therapeutics, Inc. | 5.30B | 0.06% | 261,750 | 1.16B |
| 161 | SRRK | Scholar Rock Holding Corporation | 5.29B | 0.44% | 400,156 | 570.00K |
| 162 | GRAL | GRAIL, Inc. | 5.23B | -4.05% | 251,855 | 166.60M |
| 163 | LQDA | Liquidia Corporation | 5.21B | -0.53% | 1,268,527 | 621.87M |
| 164 | MMSI | Merit Medical Systems, Inc. | 5.18B | -0.27% | 154,220 | 1.61B |
| 165 | DNTH | Dianthus Therapeutics, Inc. | 5.18B | -0.61% | 345,840 | 2.72M |
| 166 | BLLN | BillionToOne, Inc. | 5.12B | -3.27% | 507,254 | 436.87M |
| 167 | MMED | MiniMed Group, Inc. | 5.07B | 0.90% | 3,394,542 | 3.22B |
| 168 | EWTX | Edgewise Therapeutics, Inc. | 5.06B | 0.94% | 676,098 | - |
| 169 | LIVN | LivaNova PLC | 5.01B | 0.84% | 407,795 | 1.51B |
| 170 | COGT | Cogent Biosciences, Inc. | 4.98B | -1.75% | 626,832 | - |
| 171 | TVTX | Travere Therapeutics, Inc. | 4.88B | -1.45% | 462,156 | 651.03M |
| 172 | IONS | Ionis Pharmaceuticals, Inc. | 4.78B | 5.09% | 3,858,954 | 960.09M |
| 173 | OPCH | Option Care Health, Inc. | 4.74B | -0.08% | 1,444,522 | 5.75B |
| 174 | SHC | Sotera Health Company | 4.74B | 1.81% | 1,541,598 | 1.23B |
| 175 | ADPT | Adaptive Biotechnologies Corporation | 4.72B | -1.05% | 1,228,610 | 298.01M |
| 176 | HIMS | Hims & Hers Health, Inc. | 4.64B | 0.30% | 8,097,342 | 2.87B |
| 177 | ICUI | ICU Medical, Inc. | 4.46B | 0.56% | 100,174 | 2.18B |
| 178 | DFTX | Definium Therapeutics, Inc. | 4.40B | -2.52% | 551,030 | - |
| 179 | STVN | Stevanato Group S.p.A. | 4.32B | 10.03% | 1,169,830 | 1.42B |
| 180 | ITGR | Integer Holdings Corporation | 4.31B | 0.18% | 616,666 | 1.83B |
| 181 | HTFL | HeartFlow, Inc. | 4.28B | -18.64% | 2,801,785 | 238.66M |
| 182 | TNGX | Tango Therapeutics, Inc. | 4.28B | 1.73% | 1,510,058 | 53.81M |
| 183 | CDNA | CareDx, Inc. | 4.13B | -1.48% | 562,066 | 497.40M |
| 184 | CRSP | CRISPR Therapeutics AG | 4.09B | -1.17% | 1,446,258 | 25.17M |
| 185 | RLAY | Relay Therapeutics, Inc. | 4.00B | 0.22% | 1,001,420 | 10.35M |
| 186 | XENE | Xenon Pharmaceuticals Inc. | 3.99B | -0.91% | 345,973 | 7.50M |
| 187 | TARS | Tarsus Pharmaceuticals, Inc. | 3.97B | 4.59% | 470,927 | 682.20M |
| 188 | NVST | Envista Holdings Corporation | 3.93B | -0.53% | 917,101 | 2.88B |
| 189 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.89B | 1.41% | 1,121,913 | -665.00K |
| 190 | PLSE | Pulse Biosciences, Inc. | 3.84B | -0.10% | 315,202 | 1.49M |
| 191 | ABCL | AbCellera Biologics Inc. | 3.75B | -0.52% | 2,166,512 | 67.85M |
| 192 | VKTX | Viking Therapeutics, Inc. | 3.69B | 4.89% | 7,518,759 | - |
| 193 | IRON | Disc Medicine, Inc. | 3.66B | -3.52% | 444,666 | - |
| 194 | OGN | Organon & Co. | 3.65B | -0.11% | 2,862,970 | 6.10B |
| 195 | ELVN | Enliven Therapeutics, Inc. | 3.59B | 0.89% | 721,598 | - |
| 196 | IOVA | Iovance Biotherapeutics, Inc. | 3.59B | 1.57% | 6,676,058 | 378.98M |
| 197 | ARQT | Arcutis Biotherapeutics, Inc. | 3.57B | 2.69% | 567,814 | 508.68M |
| 198 | PBLS | Parabilis Medicines, Inc. | 3.52B | 1.55% | 281,915 | 2.26M |
| 199 | ACHC | Acadia Healthcare Company, Inc. | 3.51B | -0.24% | 907,830 | 3.41B |
| 200 | VRDN | Viridian Therapeutics, Inc. | 3.49B | 0.79% | 778,281 | 26.31M |
| 201 | SGRY | Surgery Partners, Inc. | 3.48B | 1.05% | 1,824,461 | 3.36B |
| 202 | WRBY | Warby Parker Inc. | 3.40B | 2.19% | 1,682,535 | 934.66M |
| 203 | LEGN | Legend Biotech Corporation | 3.39B | -5.72% | 2,436,080 | 1.36B |
| 204 | AXGN | Axogen, Inc. | 3.33B | 0.56% | 931,884 | 266.93M |
| 205 | NHC | National HealthCare Corporation | 3.27B | -0.96% | 57,177 | 1.58B |
| 206 | DYN | Dyne Therapeutics, Inc. | 3.22B | 1.00% | 1,230,874 | - |
| 207 | ACAD | Acadia Pharmaceuticals Inc. | 3.21B | 2.48% | 877,711 | 1.20B |
| 208 | TMDX | TransMedics Group, Inc. | 3.19B | -0.03% | 577,304 | 727.65M |
| 209 | CELC | Celcuity Inc. | 3.15B | 0.05% | 453,640 | - |
| 210 | PRVA | Privia Health Group, Inc. | 3.15B | 4.10% | 1,108,130 | 2.43B |
| 211 | GRDN | Guardian Pharmacy Services, Inc. | 3.14B | 0.24% | 202,759 | 1.46B |
| 212 | BHC | Bausch Health Companies Inc. | 3.12B | 1.09% | 1,750,968 | 11.11B |
| 213 | TLX | Telix Pharmaceuticals Limited | 3.09B | -1.23% | 75,994 | 890.79M |
| 214 | IRTC | iRhythm Holdings, Inc. | 3.08B | -2.08% | 630,150 | 854.04M |
| 215 | ADMA | ADMA Biologics, Inc. | 3.06B | 4.31% | 2,926,782 | 519.15M |
| 216 | IDYA | IDEAYA Biosciences, Inc. | 3.06B | 0.60% | 496,397 | 36.54M |
| 217 | XERS | Xeris Biopharma Holdings, Inc. | 3.04B | 0.00% | 1,661,834 | 368.26M |
| 218 | DNLI | Denali Therapeutics Inc. | 3.00B | -0.95% | 442,246 | 21.38M |
| 219 | VCEL | Vericel Corporation | 2.93B | -0.05% | 338,683 | 324.17M |
| 220 | ATRC | AtriCure, Inc. | 2.90B | 1.59% | 341,899 | 589.80M |
| 221 | MBX | MBX Biosciences, Inc. | 2.80B | 3.58% | 195,696 | - |
| 222 | XNCR | Xencor, Inc. | 2.80B | -2.18% | 640,019 | 200.49M |
| 223 | ZLAB | Zai Lab Limited | 2.75B | -5.95% | 1,005,903 | 441.73M |
| 224 | PGNY | Progyny, Inc. | 2.67B | -0.97% | 528,636 | 1.34B |
| 225 | CLOV | Clover Health Investments, Corp. | 2.63B | 0.61% | 3,321,404 | 2.74B |
| 226 | HCM | HUTCHMED (China) Limited | 2.57B | 0.71% | 17,008 | 549.12M |
| 227 | ARDT | Ardent Health, Inc. | 2.51B | 0.68% | 580,567 | 6.45B |
| 228 | AVAH | Aveanna Healthcare Holdings Inc. | 2.51B | -6.29% | 2,684,505 | 2.68B |
| 229 | RCUS | Arcus Biosciences, Inc. | 2.50B | -2.36% | 510,385 | 100.00M |
| 230 | NEOG | Neogen Corporation | 2.46B | 0.71% | 687,854 | 884.00M |
| 231 | RGC | Regencell Bioscience Holdings Limited | 2.42B | -4.59% | 107,438 | - |
| 232 | NAMS | NewAmsterdam Pharma Company N.V. | 2.42B | 1.15% | 1,355,679 | 25.94M |
| 233 | MD | Pediatrix Medical Group, Inc. | 2.39B | -0.19% | 235,950 | 1.96B |
| 234 | UFPT | UFP Technologies, Inc. | 2.37B | -0.01% | 46,925 | 649.52M |
| 235 | PHVS | Pharvaris N.V. | 2.36B | -0.62% | 117,666 | - |
| 236 | BEAM | Beam Therapeutics Inc. | 2.28B | -4.91% | 1,559,996 | 146.64M |
| 237 | CLDX | Celldex Therapeutics, Inc. | 2.26B | 0.98% | 345,702 | 158.00K |
| 238 | PRGO | Perrigo Company plc | 2.24B | -0.06% | 495,090 | 4.09B |
| 239 | ADUS | Addus HomeCare Corporation | 2.24B | -0.61% | 69,172 | 1.50B |
| 240 | PVLA | Palvella Therapeutics, Inc. | 2.23B | -0.39% | 186,989 | - |
| 241 | SDGR | Schrödinger, Inc. | 2.21B | -4.44% | 961,692 | 269.20M |
| 242 | IMNM | Immunome, Inc. | 2.21B | 0.16% | 652,208 | 4.02M |
| 243 | LKFT | Lakefront Biotherapeutics NV | 2.20B | 0.22% | 238,163 | 1.13B |
| 244 | BKD | Brookdale Senior Living Inc. | 2.18B | 1.84% | 9,260,745 | 2.86B |
| 245 | PBH | Prestige Consumer Healthcare Inc. | 2.18B | 1.58% | 311,960 | 1.17B |
| 246 | ALMR | Alamar Biosciences, Inc. | 2.14B | -2.93% | 460,113 | 114.05M |
| 247 | AUPH | Aurinia Pharmaceuticals Inc. | 2.13B | -2.10% | 468,789 | 321.74M |
| 248 | ESTA | Establishment Labs Holdings Inc. | 2.13B | 3.89% | 264,214 | 264.03M |
| 249 | TRLV | Trulieve Cannabis Corp. | 2.09B | -2.87% | 807,309 | 1.08B |
| 250 | BHVN | Biohaven Ltd. | 2.08B | -2.13% | 776,598 | - |
| 251 | REPL | Replimune Group, Inc. | 2.07B | -0.61% | 1,304,817 | - |
| 252 | NEO | NeoGenomics, Inc. | 2.07B | -3.39% | 1,328,957 | 787.75M |
| 253 | VERA | Vera Therapeutics, Inc. | 2.05B | -2.50% | 715,473 | 10.28M |
| 254 | SEPN | Septerna, Inc. | 2.01B | 1.03% | 242,961 | 96.27M |
| 255 | RXRX | Recursion Pharmaceuticals, Inc. | 1.99B | -3.90% | 14,498,882 | 68.23M |
| 256 | TRAX | First Tracks Biotherapeutics, Inc. | 1.99B | -2.94% | 264,889 | - |
| 257 | HRMY | Harmony Biosciences Holdings, Inc. | 1.98B | -0.49% | 599,108 | 989.36M |
| 258 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.97B | -1.50% | 1,421,342 | 213.00M |
| 259 | VCYT | Veracyte, Inc. | 1.97B | -1.10% | 1,224,594 | 581.78M |
| 260 | FTRE | Fortrea Holdings Inc. | 1.96B | 1.45% | 1,083,543 | 2.67B |
| 261 | BCRX | BioCryst Pharmaceuticals, Inc. | 1.95B | -1.11% | 1,031,473 | 961.51M |
| 262 | TRVI | Trevi Therapeutics, Inc. | 1.95B | 0.66% | 726,289 | - |
| 263 | AGL | agilon health, inc. | 1.95B | 5.17% | 102,073 | 6.00B |
| 264 | COAG | Hemab Therapeutics Holdings, Inc. | 1.90B | 3.52% | 252,919 | - |
| 265 | ZBIO | Zenas BioPharma, Inc. | 1.90B | 1.52% | 214,882 | 11.00M |
| 266 | AGIO | Agios Pharmaceuticals, Inc. | 1.89B | -0.41% | 212,262 | 140.84M |
| 267 | MAZE | Maze Therapeutics, Inc. | 1.88B | -4.63% | 1,070,401 | 20.00M |
| 268 | AZTA | Azenta, Inc. | 1.88B | 2.55% | 573,464 | 621.70M |
| 269 | ETON | Eton Pharmaceuticals, Inc. | 1.84B | 3.73% | 484,667 | 141.06M |
| 270 | LYCA | Lycia Therapeutics, Inc. | 1.83B | -3.12% | 128,962 | 4.44M |
| 271 | XRAY | DENTSPLY SIRONA Inc. | 1.82B | -0.54% | 2,795,020 | 3.58B |
| 272 | ZYME | Zymeworks Inc. | 1.81B | -1.13% | 578,916 | 265.97M |
| 273 | LMAT | LeMaitre Vascular, Inc. | 1.80B | 1.13% | 110,809 | 269.36M |
| 274 | CERT | Certara, Inc. | 1.77B | -2.52% | 1,801,512 | 425.76M |
| 275 | INSP | Inspire Medical Systems, Inc. | 1.77B | 0.73% | 289,888 | 880.94M |
| 276 | STOK | Stoke Therapeutics, Inc. | 1.74B | 1.53% | 228,652 | 28.21M |
| 277 | KMTS | Kestra Medical Technologies, Ltd. | 1.73B | 1.33% | 217,156 | 106.73M |
| 278 | KLRA | Kailera Therapeutics, Inc. | 1.72B | 0.38% | 327,453 | - |
| 279 | SRPT | Sarepta Therapeutics, Inc. | 1.72B | 0.25% | 909,932 | 1.96B |
| 280 | MESO | Mesoblast Limited | 1.72B | 0.53% | 293,083 | 120.25M |
| 281 | PSNL | Personalis, Inc. | 1.70B | -0.95% | 2,406,099 | 80.77M |
| 282 | NRIX | Nurix Therapeutics, Inc. | 1.69B | -0.74% | 899,424 | 701.94M |
| 283 | WWB | Windward Bio Group AG | 1.69B | 71.41% | 1,220,238 | - |
| 284 | QURE | uniQure N.V. | 1.68B | -2.60% | 1,133,058 | 20.17M |
| 285 | HCSG | Healthcare Services Group, Inc. | 1.68B | -0.52% | 139,003 | 1.88B |
| 286 | VIR | Vir Biotechnology, Inc. | 1.68B | -19.31% | 14,378,871 | 302.80M |
| 287 | BFLY | Butterfly Network, Inc. | 1.64B | -8.17% | 3,330,075 | 123.26M |
| 288 | ADRX | ADARx Pharmaceuticals, Inc. | 1.64B | -2.01% | 363,392 | 6.13M |
| 289 | RARE | Ultragenyx Pharmaceutical Inc. | 1.63B | -1.29% | 1,053,738 | 730.00M |
| 290 | PGEN | Precigen, Inc. | 1.63B | -2.58% | 2,625,971 | 156.94M |
| 291 | ASTH | Astrana Health, Inc. | 1.62B | -0.60% | 147,979 | 3.91B |
| 292 | BRVE | Braveheart Bio, Inc. | 1.62B | -3.46% | 468,791 | - |
| 293 | OMCL | Omnicell, Inc. | 1.61B | 0.03% | 170,400 | 1.24B |
| 294 | SNDA | Sonida Senior Living, Inc. | 1.61B | -0.06% | 186,528 | 593.56M |
| 295 | ENOV | Enovis Corporation | 1.60B | 0.45% | 751,862 | 2.31B |
| 296 | TDOC | Teladoc Health, Inc. | 1.60B | 0.69% | 2,085,539 | 2.47B |
| 297 | SLS | SELLAS Life Sciences Group, Inc. | 1.59B | -2.99% | 9,058,017 | - |
| 298 | WGS | GeneDx Holdings Corp. | 1.56B | 0.62% | 895,582 | 460.78M |
| 299 | NBTX | Nanobiotix S.A. | 1.56B | -4.34% | 83,634 | 13.15M |
| 300 | GENB | Generate Biomedicines, Inc. | 1.55B | -4.38% | 638,526 | 21.07M |
| 301 | RAPP | Rapport Therapeutics, Inc. | 1.55B | 0.85% | 151,124 | 20.00M |
| 302 | IMCR | Immunocore Holdings plc | 1.54B | -1.92% | 204,469 | 429.30M |
| 303 | ALHC | Alignment Healthcare, Inc. | 1.54B | -1.60% | 1,832,950 | 4.94B |
| 304 | ANIP | ANI Pharmaceuticals, Inc. | 1.52B | 1.11% | 169,148 | 1.04B |
| 305 | CNMD | CONMED Corporation | 1.51B | 0.20% | 107,262 | 1.37B |
| 306 | ALVO | Alvotech | 1.50B | -10.28% | 1,847,710 | 492.31M |
| 307 | USPH | U.S. Physical Therapy, Inc. | 1.49B | 1.05% | 84,662 | 829.86M |
| 308 | ABSI | Absci Corporation | 1.46B | -7.17% | 4,253,080 | 1.49M |
| 309 | PCRX | Pacira BioSciences, Inc. | 1.46B | -0.01% | 1,655,834 | 743.30M |
| 310 | AMN | AMN Healthcare Services, Inc. | 1.46B | 1.28% | 303,038 | 3.52B |
| 311 | PAHC | Phibro Animal Health Corporation | 1.46B | 1.41% | 232,437 | 1.54B |
| 312 | KRSA | Korsana Biosciences, Inc. | 1.45B | 1.73% | 192,603 | - |
| 313 | LMRI | Lumexa Imaging Holdings, Inc. | 1.44B | 0.00% | 187,520 | 1.06B |
| 314 | GPCR | Structure Therapeutics Inc. | 1.43B | 0.76% | 977,745 | - |
| 315 | NVAX | Novavax, Inc. | 1.41B | -2.51% | 3,698,904 | 411.65M |
| 316 | NUVB | Nuvation Bio Inc. | 1.41B | -1.85% | 2,267,499 | 201.73M |
| 317 | NTLA | Intellia Therapeutics, Inc. | 1.41B | -5.02% | 3,926,402 | 52.89M |
| 318 | LBRX | LB Pharmaceuticals Inc | 1.40B | 1.66% | 276,281 | - |
| 319 | TNDM | Tandem Diabetes Care, Inc. | 1.39B | 13.59% | 3,472,325 | 1.08B |
| 320 | TYRA | Tyra Biosciences, Inc. | 1.38B | 1.14% | 223,246 | - |
| 321 | PRCT | PROCEPT BioRobotics Corporation | 1.38B | 1.87% | 643,940 | 352.31M |
| 322 | NVCR | NovoCure Limited | 1.37B | 0.34% | 674,790 | 725.39M |
| 323 | ANAB | AnaptysBio, Inc. | 1.37B | -3.27% | 376,882 | 60.04M |
| 324 | OCUL | Ocular Therapeutix, Inc. | 1.37B | -0.64% | 1,651,800 | 50.38M |
| 325 | MLYS | Mineralys Therapeutics, Inc. | 1.36B | -0.77% | 920,304 | - |
| 326 | INVA | Innoviva, Inc. | 1.35B | 0.21% | 344,831 | 438.32M |
| 327 | DMRA | Damora Therapeutics, Inc. | 1.34B | -2.00% | 381,179 | - |
| 328 | TSHA | Taysha Gene Therapies, Inc. | 1.34B | -2.61% | 1,729,084 | 5.49M |
| 329 | STAA | STAAR Surgical Company | 1.33B | -0.71% | 248,484 | 328.27M |
| 330 | MNKD | MannKind Corporation | 1.33B | -0.96% | 1,173,852 | 413.37M |
| 331 | AVLN | Avalyn Pharma Inc. | 1.32B | -2.48% | 428,599 | - |
| 332 | AAPG | Ascentage Pharma Group International | 1.30B | -1.13% | 8,269 | 94.61M |
| 333 | KARD | Kardigan, Inc. | 1.30B | -1.42% | 303,272 | - |
| 334 | INNV | InnovAge Holding Corp. | 1.29B | 0.96% | 211,509 | 1.02B |
| 335 | GHRS | GH Research PLC | 1.29B | 1.78% | 450,255 | - |
| 336 | CMPS | COMPASS Pathways plc | 1.28B | -0.99% | 2,380,059 | - |
| 337 | URGN | UroGen Pharma Ltd. | 1.27B | -1.55% | 281,541 | 250.25M |
| 338 | NKTR | Nektar Therapeutics | 1.27B | 0.19% | 471,493 | 52.19M |
| 339 | PNTG | The Pennant Group, Inc. | 1.27B | 0.81% | 277,030 | 1.17B |
| 340 | OMER | Omeros Corporation | 1.27B | -2.56% | 465,302 | 38.42M |
| 341 | SVRA | Savara Inc. | 1.27B | -0.42% | 2,153,053 | - |
| 342 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.25B | 1.85% | 226,269 | 745.79M |
| 343 | OPK | OPKO Health, Inc. | 1.25B | 0.60% | 1,750,758 | 654.10M |
| 344 | CRON | Cronos Group Inc. | 1.24B | -0.44% | 537,414 | 206.20M |
| 345 | DRTS | Alpha Tau Medical Ltd. | 1.23B | 0.07% | 332,614 | - |
| 346 | SLN | Silence Therapeutics plc | 1.23B | 0.20% | 513,792 | 615.00K |
| 347 | GDRX | GoodRx Holdings, Inc. | 1.22B | 2.14% | 612,214 | 785.23M |
| 348 | INBX | Inhibrx Biosciences, Inc. | 1.21B | -6.38% | 169,351 | 1.30M |
| 349 | ANRO | Alto Neuroscience, Inc. | 1.20B | -2.19% | 431,686 | - |
| 350 | NUTX | Nutex Health Inc. | 1.19B | 1.49% | 58,216 | 796.53M |
| 351 | VOR | Vor Biopharma Inc. | 1.18B | -0.52% | 486,129 | - |
| 352 | HROW | Harrow, Inc. | 1.12B | 5.72% | 622,290 | 303.25M |
| 353 | AHG | Akso Health Group | 1.12B | -2.60% | 2,495 | 13.83M |
| 354 | IART | Integra LifeSciences Holdings Corporation | 1.12B | 0.42% | 372,064 | 1.66B |
| 355 | FRNM | Freenome, Inc. | 1.12B | -2.07% | 417,438 | 217.86M |
| 356 | SGP | SpyGlass Pharma, Inc. | 1.11B | -0.84% | 24,416 | - |
| 357 | ATEC | Alphatec Holdings, Inc. | 1.10B | 0.35% | 1,823,246 | 839.72M |
| 358 | IRMD | IRADIMED CORPORATION | 1.09B | -0.07% | 22,364 | 89.34M |
| 359 | SPTX | Seaport Therapeutics, Inc. | 1.07B | -0.50% | 269,942 | - |
| 360 | MLTX | MoonLake Immunotherapeutics | 1.07B | -2.18% | 748,059 | - |
| 361 | SIBN | SI-BONE, Inc. | 1.07B | -2.09% | 243,726 | 220.65M |
| 362 | CSTL | Castle Biosciences, Inc. | 1.05B | -1.54% | 177,013 | 377.13M |
| 363 | VSTM | Verastem, Inc. | 1.04B | -1.95% | 1,062,219 | 100.30M |
| 364 | JBIO | Jade Biosciences, Inc. | 1.03B | 2.14% | 387,362 | - |
| 365 | GMRS | GMR Solutions Inc. | 1.03B | 0.88% | 1,097,565 | 5.97B |
| 366 | CBLL | CeriBell, Inc. | 1.02B | -0.23% | 171,118 | 108.72M |
| 367 | AHCO | AdaptHealth Corp. | 1.02B | -3.30% | 1,279,858 | 3.44B |
| 368 | AORT | Artivion, Inc. | 927.98M | -1.96% | 339,614 | 481.88M |
| 369 | AKTS | Aktis Oncology, Inc. | 924.95M | 2.15% | 170,557 | 12.39M |
| 370 | ODTX | Odyssey Therapeutics, Inc. | 912.32M | -5.32% | 206,813 | 99.00K |
| 371 | BVS | Bioventus Inc. | 910.86M | -0.46% | 419,590 | 585.64M |
| 372 | MGTX | MeiraGTx Holdings plc | 899.12M | 4.66% | 476,653 | 401.91M |
| 373 | CRVS | Corvus Pharmaceuticals, Inc. | 895.83M | 0.00% | 403,473 | - |
| 374 | OMDA | Omada Health, Inc. | 895.20M | -1.84% | 613,536 | 333.04M |
| 375 | PHAR | Pharming Group N.V. | 894.35M | -1.62% | 4,859 | 386.75M |
| 376 | BBNX | Beta Bionics, Inc. | 889.45M | -0.91% | 807,116 | 127.27M |
| 377 | IMTX | Immatics N.V. | 869.35M | -2.45% | 392,427 | 49.33M |
| 378 | HSTM | HealthStream, Inc. | 860.48M | -0.71% | 97,193 | 327.95M |
| 379 | CTY | City Therapeutics, Inc. | 853.83M | -9.59% | 430,915 | 14.34M |
| 380 | LTGO | Latigo Biotherapeutics, Inc. | 849.96M | -0.85% | 345,911 | - |
| 381 | KIDS | OrthoPediatrics Corp. | 847.94M | -0.32% | 61,488 | 264.14M |
| 382 | IVA | Inventiva S.A. | 844.03M | -4.51% | 2,354,833 | 2.81M |
| 383 | SNDX | Syndax Pharmaceuticals, Inc. | 835.46M | -2.73% | 1,803,090 | 289.68M |
| 384 | RIGL | Rigel Pharmaceuticals, Inc. | 829.27M | -3.61% | 80,428 | 288.21M |
| 385 | BBTX | Bambusa Therapeutics, Inc. | 825.27M | -3.28% | 303,380 | - |
| 386 | ORIC | ORIC Pharmaceuticals, Inc. | 818.34M | -7.12% | 584,178 | - |
| 387 | IRWD | Ironwood Pharmaceuticals, Inc. | 806.23M | 0.41% | 1,790,582 | 400.30M |
| 388 | GLUE | Monte Rosa Therapeutics, Inc. | 801.52M | 0.75% | 785,076 | 70.33M |
| 389 | LXRX | Lexicon Pharmaceuticals, Inc. | 796.97M | -1.65% | 1,486,666 | 38.54M |
| 390 | COLL | Collegium Pharmaceutical, Inc. | 788.69M | 1.72% | 259,017 | 815.19M |
| 391 | PHR | Phreesia, Inc. | 787.99M | 0.59% | 274,826 | 507.79M |
| 392 | ARDX | Ardelyx, Inc. | 781.77M | -0.32% | 1,666,825 | 468.22M |
| 393 | OBX | Obsidian Therapeutics, Inc. | 778.03M | 0.92% | 225,228 | - |
| 394 | SLDB | Solid Biosciences Inc. | 773.46M | -1.00% | 711,671 | - |
| 395 | VREX | Varex Imaging Corporation | 764.14M | -0.77% | 569,621 | 865.00M |
| 396 | CTKB | Cytek Biosciences, Inc. | 763.78M | 5.80% | 902,102 | 207.65M |
| 397 | INMD | InMode Ltd. | 759.03M | 0.11% | 348,681 | 373.60M |
| 398 | PRME | Prime Medicine, Inc. | 757.52M | 9.13% | 4,884,513 | 7.06M |
| 399 | ANNX | Annexon, Inc. | 749.70M | -1.01% | 1,885,972 | - |
| 400 | AURA | Aura Biosciences, Inc. | 739.97M | 0.00% | 430,686 | - |
| 401 | ALMS | Alumis Inc. | 737.38M | -7.34% | 865,064 | 7.24M |
| 402 | QDEL | QuidelOrtho Corporation | 734.50M | 0.80% | 1,263,553 | 2.59B |
| 403 | SGMT | Sagimet Biosciences Inc. | 730.09M | -6.40% | 559,410 | - |
| 404 | DCTH | Delcath Systems, Inc. | 720.29M | -3.16% | 503,210 | 109.96M |
| 405 | OABI | OmniAb, Inc. | 719.09M | -0.40% | 608,857 | 40.21M |
| 406 | KURA | Kura Oncology, Inc. | 710.22M | 4.04% | 1,552,840 | 79.31M |
| 407 | SOPH | SOPHiA GENETICS SA | 704.11M | 4.58% | 484,503 | 90.97M |
| 408 | JANX | Janux Therapeutics, Inc. | 701.16M | -0.30% | 520,178 | 23.29M |
| 409 | APMD | Apnimed, Inc. | 696.48M | 0.60% | 624,171 | 115.12M |
| 410 | FLGT | Fulgent Genetics, Inc. | 694.56M | 0.04% | 175,849 | 330.28M |
| 411 | ANL | Adlai Nortye Group Ltd. | 692.28M | 2.19% | 122,499 | 18.06M |
| 412 | NVCT | Nuvectis Pharma, Inc. | 691.56M | -0.59% | 178,256 | - |
| 413 | ATTO | Attovia Therapeutics, Inc. | 685.68M | -5.00% | 204,534 | 1.44M |
| 414 | FDMT | 4D Molecular Therapeutics, Inc. | 684.45M | 0.21% | 619,285 | 96.06M |
| 415 | AVBP | ArriVent BioPharma, Inc. | 674.47M | -0.23% | 405,628 | 5.00M |
| 416 | DSGN | Design Therapeutics, Inc. | 671.10M | -0.95% | 109,589 | - |
| 417 | CGEM | Cullinan Therapeutics, Inc. | 666.09M | 0.69% | 913,642 | - |
| 418 | OLMA | Olema Pharmaceuticals, Inc. | 665.81M | 1.06% | 1,183,598 | - |
| 419 | BCAX | Bicara Therapeutics Inc. | 659.22M | -1.78% | 717,751 | - |
| 420 | IMMX | Immix Biopharma, Inc. | 658.77M | -2.60% | 712,065 | - |
| 421 | DBVT | DBV Technologies S.A. | 648.00M | -4.99% | 236,910 | 3.74M |
| 422 | HELP | Helus Pharma Inc. | 645.85M | -0.23% | 639,713 | - |
| 423 | ACRS | Aclaris Therapeutics, Inc. | 624.93M | -1.50% | 873,955 | 6.40M |
| 424 | ABUS | Arbutus Biopharma Corporation | 623.90M | 0.99% | 2,336,828 | 181.49M |
| 425 | GERN | Geron Corporation | 622.14M | -2.85% | 3,931,269 | 217.52M |
| 426 | IAM | Iambic Therapeutics, Inc. | 619.53M | -11.93% | 255,280 | 18.25M |
| 427 | DNA | Ginkgo Bioworks Holdings, Inc. | 619.00M | -6.65% | 1,368,825 | 130.75M |
| 428 | WVE | Wave Life Sciences, Inc. | 616.34M | -0.95% | 1,758,661 | 70.92M |
| 429 | CLYM | Climb Bio, Inc. | 610.29M | -4.42% | 470,969 | - |
| 430 | CBIO | Crescent Biopharma, Inc. | 609.92M | -0.84% | 190,726 | 15.00M |
| 431 | PACB | Pacific Biosciences of California, Inc. | 608.64M | -1.27% | 5,841,714 | 161.39M |
| 432 | TCMD | Tactile Systems Technology, Inc. | 601.92M | 0.19% | 110,257 | 356.42M |
| 433 | SANA | Sana Biotechnology, Inc. | 600.77M | -0.25% | 2,766,437 | - |
| 434 | SGHT | Sight Sciences, Inc. | 600.25M | -1.73% | 162,069 | 88.40M |
| 435 | SRZN | Surrozen, Inc. | 592.53M | -1.85% | 71,091 | 10.53M |
| 436 | EVO | Evotec SE | 588.16M | -4.22% | 44,906 | 815.72M |
| 437 | SENS | Senseonics Holdings, Inc. | 573.00M | 4.18% | 842,062 | 60.01M |
| 438 | OBIO | Orchestra BioMed Holdings, Inc. | 566.68M | 17.07% | 1,155,211 | 31.21M |
| 439 | NRC | NRC Health | 561.52M | -0.68% | 76,709 | 143.79M |
| 440 | CAPR | Capricor Therapeutics, Inc. | 557.00M | -6.45% | 3,153,330 | 11.13M |
| 441 | ZVRA | Zevra Therapeutics, Inc. | 551.61M | -16.94% | 2,261,202 | 147.76M |
| 442 | EVH | Evolent Health, Inc. | 550.82M | 2.10% | 758,589 | 2.34B |
| 443 | ETRA | Electra Therapeutics, Inc. | 546.70M | -4.39% | 214,885 | - |
| 444 | VALN | Valneva SE | 545.09M | -1.56% | 2,124 | 163.30M |
| 445 | MYGN | Myriad Genetics, Inc. | 543.40M | -0.26% | 613,029 | 803.60M |
| 446 | ENTX | Entera Bio Ltd. | 543.31M | -3.11% | 91,036 | 42.00K |
| 447 | AVR | Anteris Technologies Global Corp. | 531.34M | -7.00% | 852,103 | 2.33M |
| 448 | EPRX | Eupraxia Pharmaceuticals Inc. | 530.67M | 3.33% | 557,284 | - |
| 449 | TKNO | Alpha Teknova, Inc. | 512.66M | -1.75% | 273,238 | 45.95M |
| 450 | RGNX | REGENXBIO Inc. | 505.84M | -4.73% | 509,889 | 153.91M |
| 451 | NGNE | Neurogene Inc. | 499.72M | 1.00% | 133,032 | 925.00K |
| 452 | SRTA | Strata Critical Medical, Inc. | 498.40M | -3.29% | 630,361 | 280.76M |
| 453 | ANGO | AngioDynamics, Inc. | 498.35M | -1.13% | 172,351 | 325.38M |
| 454 | MNPR | Monopar Therapeutics Inc. | 493.62M | 0.22% | 171,627 | - |
| 455 | RCEL | AVITA Medical, Inc. | 493.30M | -3.09% | 402,255 | 84.68M |
| 456 | INDP | Indaptus Therapeutics, Inc. | 488.39M | 0.95% | 72,279 | - |
| 457 | AQST | Aquestive Therapeutics, Inc. | 488.30M | 8.82% | 3,221,535 | 48.84M |
| 458 | CADL | Candel Therapeutics, Inc. | 484.40M | -26.40% | 5,634,676 | - |
| 459 | DMAC | DiaMedica Therapeutics Inc. | 478.06M | -5.04% | 186,323 | - |
| 460 | STTK | Shattuck Labs, Inc. | 476.62M | -2.70% | 567,735 | 1.00M |
| 461 | OVID | Ovid Therapeutics Inc. | 473.72M | -1.57% | 2,311,965 | 1.45M |
| 462 | OCS | Oculis Holding AG | 469.47M | 1.40% | 137,273 | 1.12M |
| 463 | PHAT | Phathom Pharmaceuticals, Inc. | 469.43M | -5.14% | 910,622 | 274.88M |
| 464 | KMDA | Kamada Ltd. | 468.46M | -0.49% | 74,915 | 196.87M |
| 465 | CARL | Carlsmed, Inc. | 467.24M | -1.45% | 125,764 | 71.78M |
| 466 | CTEV | Claritev Corporation | 464.09M | 1.04% | 131,581 | 1.02B |
| 467 | GYRE | Gyre Therapeutics, Inc. | 464.07M | -1.40% | 236,317 | 110.06M |
| 468 | MDXG | MiMedx Group, Inc. | 461.85M | -2.31% | 846,931 | 303.73M |
| 469 | EOLS | Evolus, Inc. | 460.67M | -3.06% | 343,954 | 325.47M |
| 470 | RLMD | Relmada Therapeutics, Inc. | 452.92M | 2.04% | 1,397,721 | - |
| 471 | AVTX | Avalo Therapeutics, Inc. | 450.44M | 1.17% | 637,459 | 59.00K |
| 472 | ARVN | Arvinas, Inc. | 444.64M | -1.16% | 611,767 | 275.30M |
| 473 | BLSM | BlossomHill Therapeutics, Inc. | 441.17M | -6.47% | 187,871 | - |
| 474 | CTMX | CytomX Therapeutics, Inc. | 439.28M | -1.23% | 1,781,721 | 14.03M |
| 475 | SI | Shoulder Innovations, Inc. | 438.12M | -0.66% | 168,793 | 64.49M |
| 476 | MOBI | Mobia Medical, Inc. | 436.60M | -1.58% | 99,318 | 51.89M |
| 477 | ASMB | Assembly Biosciences, Inc. | 428.18M | 3.62% | 223,845 | 67.01M |
| 478 | SLBT | SL Science Holding Limited | 424.79M | -2.54% | 22,352 | 3.27M |
| 479 | PRTA | Prothena Corporation plc | 419.01M | -0.85% | 235,364 | 52.74M |
| 480 | TECX | Tectonic Therapeutic, Inc. | 409.75M | -0.38% | 264,343 | - |
| 481 | FENC | Fennec Pharmaceuticals Inc. | 405.83M | 5.46% | 380,448 | 66.37M |
| 482 | MASS | 908 Devices Inc. | 404.18M | -0.72% | 234,258 | 65.79M |
| 483 | PBYI | Puma Biotechnology, Inc. | 402.21M | -3.71% | 266,267 | 231.83M |
| 484 | MPLT | MapLight Therapeutics, Inc. | 398.76M | 1.49% | 228,692 | - |
| 485 | BWAY | BrainsWay Ltd. | 398.72M | -2.00% | 140,845 | 60.70M |
| 486 | CERS | Cerus Corporation | 392.80M | 0.26% | 1,402,221 | 226.57M |
| 487 | CTNM | Contineum Therapeutics, Inc. | 392.66M | 2.25% | 187,243 | - |
| 488 | SPRY | ARS Pharmaceuticals, Inc. | 390.05M | 1.84% | 964,726 | 122.14M |
| 489 | RZLT | Rezolute, Inc. | 385.52M | -5.04% | 5,040,452 | - |
| 490 | IRD | Opus Genetics, Inc. | 384.68M | -1.97% | 541,483 | 7.91M |
| 491 | CRMD | CorMedix Inc. | 376.21M | -2.27% | 1,715,057 | 412.49M |
| 492 | ALEC | Alector, Inc. | 372.94M | 2.24% | 1,440,085 | 173.47M |
| 493 | TRXB | TRex Bio, Inc. | 366.95M | -3.33% | 46,128 | - |
| 494 | CCCC | C4 Therapeutics, Inc. | 365.06M | 0.36% | 2,000,210 | 32.28M |
| 495 | EMBC | Embecta Corp. | 362.90M | -0.39% | 407,576 | 1.02B |
| 496 | ASPE | Aspen Neuroscience, Inc. | 362.03M | -8.52% | 111,406 | - |
| 497 | TLRY | Tilray Brands, Inc. | 358.59M | -1.81% | 2,134,493 | 963.10M |
| 498 | STLN | Starling Oncology, Inc. | 356.97M | -6.67% | 21,546,917 | 620.45M |
| 499 | PRLD | Prelude Therapeutics Incorporated | 355.33M | -1.99% | 162,180 | 22.42M |
| 500 | LYEL | Lyell Immunopharma, Inc. | 355.02M | -7.67% | 178,733 | 15.00K |